BREAKING: Otsuka to Acquire Methylone Drug Developer Transcend in $1.23B Deal By Watertime - March 27, 2026 17 Post Content RELATED ARTICLESMORE FROM AUTHOR The Psychedelic Practitioner Issue 6: Preparedness (People) Two Years After Rejection, Resilient Quietly Refiles MDMA for PTSD Application Smooth Sailing: Definium’s LSD Voyage Hits Primary and Key Secondary Endpoints in GAD
